Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Maurizio Pompili, David Lester, Paolo Girardi & Roberto Tatarelli. (2007) High Suicide Risk After the Development of Cognitive and Working Memory Deficits Caused by Cannabis, Cocaine and Ecstasy Use. Substance Abuse 28:1, pages 25-30.
Read now
Read now
FirasH. Kobeissy, MeghanB. O'Donoghue, ErinC. Golden, StephenF. Larner, Zhiqun Zhang & MarkS. Gold. (2006) Performance Enhancement and Adverse Consequences of MDMA. Journal of Addictive Diseases 25:sup1, pages 47-59.
Read now
Read now
Articles from other publishers (12)
Masashi Taniguchi, Yoshio Yamamoto & Katsuji Nishi. (2013) Comparative <i>in Vitro</i> Studies of the Metabolism of Six 4-Substituted Methamphetamines and Their Inhibition of Cytochrome P450 2D6 by GC-MS with Trifluoroacetyl Derivatization. American Journal of Analytical Chemistry 04:04, pages 166-175.
Crossref
Crossref
Donald G. BarcelouxBrandon Wills & Timothy Erickson. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
156
192
.
M.-H. Ghysel-Laporte, P. Sibille & N. Milan. 2012. Traité De Toxicologie Médico-judiciaire. Traité De Toxicologie Médico-judiciaire
455
505
.
Folker Westphal, Cornelia Franzelius, Jon Schäfer, Hans Werner Schütz & Gertrud Rochholz. (2007) Development of a validated method for the simultaneous determination of amphetamine, methamphetamine and methylenedioxyamphetamines (MDA, MDMA, MDEA) in serum by GC-MS after derivatisation with perfluorooctanoyl chloride. Accreditation and Quality Assurance 12:7, pages 335-342.
Crossref
Crossref
JEFFREY BRENT & ROBERT PALMER. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
561
577
.
Roland W. Freudenmann & Manfred Spitzer. (2006) The Neuropsychopharmacology and Toxicology of 3,4‐methylenedioxy‐N‐ethyl‐amphetamine (MDEA). CNS Drug Reviews 10:2, pages 89-116.
Crossref
Crossref
Karine M Clauwaert, Jan F Van Bocxlaer & André P De Leenheer. (2001) Stability study of the designer drugs “MDA, MDMA and MDEA” in water, serum, whole blood, and urine under various storage temperatures. Forensic Science International 124:1, pages 36-42.
Crossref
Crossref
MICHAEL SHANNON. (2000) Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pediatric Emergency Care 16:5, pages 377-380.
Crossref
Crossref
X. Allué, J.J. Sirvent, R. Olivé, A. Cardona, J. Carretero & J. Moralejo. (2000) Muerte por drogas de diseño. Anales de Pediatría 53:1, pages 56-58.
Crossref
Crossref
Vittorio Fineschi, Fabio Centini, Elena Mazzeo & Emanuela Turillazzi. (1999) Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases. Forensic Science International 104:1, pages 65-74.
Crossref
Crossref
Maria Isabel Colado, Raquel Granados, Esther O'Shea, Blanca Esteban & A. Richard Green. (2009) The Acute Effect in Rats of 3, 4‐Methylenedioxyethamphetamine (MDEA, “Eve”) on Body Temperature and Long Term Degeneration of 5‐HT Neurones in Brain: A Comparison with MDMA (“Ecstasy”). Pharmacology & Toxicology 84:6, pages 261-266.
Crossref
Crossref
K.M Hegadoren, G.B Baker & M Bourin. (1999) 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans. Neuroscience & Biobehavioral Reviews 23:4, pages 539-553.
Crossref
Crossref